Observers Say Fisher Case Highlights Flaws In System

GREAT EXPENSE: Pittsburgh’s Bernard Fisher says that the government’s misconduct investigation against him cost too much. As renowned University of Pittsburgh cancer surgeon Bernard Fisher regroups after being cleared of misconduct in a highly publicized case, many observers are viewing the affair as a warning that the scientific community and the public need better ways of monitoring research activities. Fisher, cleared earlier this month of any wrongdoing, has filed a lawsuit ag

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share


GREAT EXPENSE: Pittsburgh’s Bernard Fisher says that the government’s misconduct investigation against him cost too much.
As renowned University of Pittsburgh cancer surgeon Bernard Fisher regroups after being cleared of misconduct in a highly publicized case, many observers are viewing the affair as a warning that the scientific community and the public need better ways of monitoring research activities.

Fisher, cleared earlier this month of any wrongdoing, has filed a lawsuit against the National Institutes of Health, the National Cancer Institute (NCI), the Office of Research Integrity (ORI), and the University of Pittsburgh. In his suit, he alleges his First Amendment rights were breached in the handling of the investigation and that he was denied due process under the law. He also contends that patients had to deal with undue concerns raised by an inaccurate portrayal of scientific research by legislators and the media. He wants to "make sure this ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Steven Benowitz

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours